Author information:
(1)Department of Medicine, Section of Rheumatology, the Knapp Center for Lupus 
and Immunology, University of Chicago, Chicago, IL 60637, USA.
(2)Department of Microbiology, Icahn School of Medicine at Mount Sinai, New 
York, NY 10029, USA.
(3)The Committee on Immunology, University of Chicago, Chicago, IL 60637, USA.
(4)Department of Chemical Engineering, University of Texas at Austin, Austin, TX 
78731, USA.
(5)Division of Viral Products, Center for Biologics Evaluation and Research, 
Food and Drug Administration, Silver Spring, MD 20993, USA.
(6)Center for Vaccine Biology & Immunology, Department of Microbiology & 
Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.
(7)Division of Infectious Disease, Department of Medicine, University of 
Rochester Medical Center, Rochester, NY 14642, USA.
(8)Emory Vaccine Center, Department of Pediatrics, Division of Infectious 
Disease, Emory University School of Medicine, Atlanta, GA 30322, USA.
(9)Department of Microbiology, Icahn School of Medicine at Mount Sinai, New 
York, NY 10029, USA. Electronic address: florian.krammer@mssm.edu.
(10)Department of Medicine, Section of Rheumatology, the Knapp Center for Lupus 
and Immunology, University of Chicago, Chicago, IL 60637, USA. Electronic 
address: wilsonp@uchicago.edu.